You are Invited to a Virtual Webinar Program on the NOW APPROVED Joenja® (leniolisib): The first and only approved treatment for Activated PI3Kδ Syndrome (APDS)

Please see below for Important Safety Information and full Prescribing Information

Please select from either of the presentations below to register for this event


Nicholas Hartog, MD
Physician and Clinical Assistant Professor
Helen DeVos Children’s Hospital
Spectrum Health Medical Group
Grand Rapids, Michigan

Tuesday, April 13, 2023 at 7:00 PM ET/4:00 PM PT


Amit R. Mehta, MD
Hematologist, Oncologist
Premier Hematology & Tele-Oncology Center, PLLC
Cary, North Carolina

Thursday, May 4, 2023 at 7:00 PM ET/4:00 PM PT

JOE-US-2023-0042v2 ©2023 Pharming, Inc. All rights reserved. Joenja and logo are registered trademarks of Pharming Intellectual Property, B.V.
For US audiences only.